Alan R. Engbring

Alan R. Engbring

Geen lopende functies

Health Technology

Oorsprong van het eerstegraads netwerk van Alan R. Engbring

EntiteitType entiteitIndustrie
34
Extinct Pharmaceuticals: Major 34

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Alan R. Engbring via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Biotechnology

Stephen Sherwin

Gary Lyons

Chief Tech/Sci/R&D Officer

Sales & Marketing

THE HERSHEY COMPANY Food: Specialty/Candy

Bob H. Campbell

Chairman

MERCK & CO., INC. Pharmaceuticals: Major

George Morrow

R. Gordon Douglas

Vijay Samant

Ronald B. Moss

David C. Kaslow

Sales & Marketing

Corporate Officer/Principal

Corporate Officer/Principal

General Counsel

Corporate Officer/Principal

NEUROCRINE BIOSCIENCES, INC. Pharmaceuticals: Major

Stephen Sherwin

George Morrow

Gary Lyons

Director/Board Member

Director/Board Member

Director/Board Member

BIOGEN INC. Pharmaceuticals: Major

Stephen Sherwin

Andrew R. de Guttadauro

Director/Board Member

Corporate Officer/Principal

Rochester Christian University College/University

Kevin R. Bracken

Thomas Evans

Graduate Degree

Corporate Officer/Principal

Miscellaneous Commercial Services

Jill Marie Church

Jill Broadfoot

Michelle L. Vandertie

Shelly Vandertie

Comptroller/Controller/Auditor

Comptroller/Controller/Auditor

Comptroller/Controller/Auditor

Corporate Officer/Principal

College/University

Alan E. Dow

Robert C. Merton

Robin M. Jackman

Phillip Young

Doctorate Degree

Corporate Officer/Principal

Doctorate Degree

Masters Business Admin

Medical Specialties

Martha Demski

Magda Marquet

Michelle L. Vandertie

Shelly Vandertie

Director of Finance/CFO

Chief Executive Officer

Director of Finance/CFO

Director of Finance/CFO

San Diego State University College/University

Jill Marie Church

Anthony Alan Ramos

Jill Broadfoot

Undergraduate Degree

Undergraduate Degree

Undergraduate Degree

Stanford University College/University

Alan E. Dow

Robin M. Jackman

Richard M. Beleson

Graduate Degree

Undergraduate Degree

Undergraduate Degree

Massachusetts Institute of Technology College/University

Bob H. Campbell

Robert C. Merton

Igor Bilinsky

Graduate Degree

Doctorate Degree

Doctorate Degree

Miscellaneous Commercial Services

R. Gordon Douglas

Vijay Samant

Thomas Evans

Chairman

Director/Board Member

Chief Executive Officer

Harvard Medical School College/University

Stephen Sherwin

Richard Kenney

Doctorate Degree

Doctorate Degree

Pharmaceuticals: Major

Alain P. Rolland

Jill Broadfoot

Chief Operating Officer

Director of Finance/CFO

FRESH TRACKS THERAPEUTICS, INC. Pharmaceuticals: Major

Gary Lyons

Vijay Samant

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Alain P. Rolland

Magda Marquet

Chief Tech/Sci/R&D Officer

Director/Board Member

George Washington University College/University

Phillip Young

Richard Kenney

Graduate Degree

Undergraduate Degree

The Trustees of Columbia University in The City of New York College/University

Vijay Samant

Robert C. Merton

Graduate Degree

Undergraduate Degree

MIT Sloan School of Management College/University

Vijay Samant

Robert C. Merton

Masters Business Admin

Corporate Officer/Principal

OTONOMY Biotechnology

George Morrow

Jill Broadfoot

Director/Board Member

Director/Board Member

Williams College College/University

Mammen P. Mammen

Thomas Evans

Undergraduate Degree

Undergraduate Degree

The University of California, San Francisco College/University

Stephen Sherwin

David C. Kaslow

Corporate Officer/Principal

Doctorate Degree

RIGEL PHARMACEUTICALS, INC. Pharmaceuticals: Major

Stephen Sherwin

Gary Lyons

Director/Board Member

Chairman

IOMAI CORPORATION Biotechnology

R. Gordon Douglas

Richard Kenney

Director/Board Member

Chief Tech/Sci/R&D Officer

Princeton University College/University

Bob H. Campbell

R. Gordon Douglas

Undergraduate Degree

Undergraduate Degree

University of Northern Colorado College/University

Michelle L. Vandertie

Shelly Vandertie

Undergraduate Degree

Undergraduate Degree

IMMUNE DESIGN CORP Pharmaceuticals: Major

Alain B. Schreiber

Richard Kenney

Director/Board Member

Chief Tech/Sci/R&D Officer

University of California, Davis College/University

David C. Kaslow

Thomas Evans

Undergraduate Degree

Corporate Officer/Principal

College/University

R. Gordon Douglas

Phillip Young

Corporate Officer/Principal

Undergraduate Degree

University of Texas Medical Branch College/University

Larry Smith

Michael Fons

Doctorate Degree

Corporate Officer/Principal

INOVIO PHARMACEUTICALS, INC. Pharmaceuticals: Major

Michael Fons

Mammen P. Mammen

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

Université Fédérale Toulouse Midi-Pyrénées College/University

Magda Marquet

Doctorate Degree

ALTHEADX INC Pharmaceuticals: Major

Magda Marquet

Founder

Miscellaneous Commercial Services

Magda Marquet

Director/Board Member

TRANSGENE Biotechnology

Magda Marquet

Corporate Officer/Principal

Magda Marquet

Director/Board Member

UCLA Anderson School of Management College/University

Richard M. Beleson

Masters Business Admin

Specialty Stores

Magda Marquet

Director/Board Member

Miscellaneous Commercial Services

Magda Marquet

Director/Board Member

Biotechnology

Magda Marquet

Chairman

Packaged Software

Magda Marquet

Director/Board Member

Pharmaceuticals: Major

Magda Marquet

Director/Board Member

ARCTURUS THERAPEUTICS HOLDINGS INC. Pharmaceuticals: Major

Magda Marquet

Director/Board Member

Miscellaneous Commercial Services

Magda Marquet

Director/Board Member

Miscellaneous Commercial Services

Magda Marquet

Director/Board Member

Statistieken

Internationaal

Verenigde Staten 46
Frankrijk 3
Italië 2
Canada 2

Sectoraal

Health Technology 21
Consumer Services 18
Commercial Services 7
Consumer Non-Durables 2
Health Services 2

Operationeel

Director/Board Member 128
Corporate Officer/Principal 92
Independent Dir/Board Member 47
Undergraduate Degree 33
Chief Tech/Sci/R&D Officer 27
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU